Silvercrest Asset Management’s Emergent Biosolutions EBS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-89,491
| Closed | -$4.48M | – | 844 |
|
|
2021
Q3 | $4.48M | Sell |
89,491
-2,462
| -3% | -$123K | 0.03% | 396 |
|
|
2021
Q2 | $5.79M | Sell |
91,953
-197,007
| -68% | -$12.4M | 0.04% | 371 |
|
|
2021
Q1 | $26.8M | Buy |
288,960
+6,276
| +2% | +$583K | 0.18% | 155 |
|
|
2020
Q4 | $25.3M | Buy |
282,684
+29,373
| +12% | +$2.63M | 0.18% | 147 |
|
|
2020
Q3 | $26.2M | Sell |
253,311
-25,342
| -9% | -$2.62M | 0.22% | 127 |
|
|
2020
Q2 | $22M | Sell |
278,653
-53,173
| -16% | -$4.2M | 0.2% | 137 |
|
|
2020
Q1 | $19.2M | Sell |
331,826
-67,156
| -17% | -$3.89M | 0.21% | 133 |
|
|
2019
Q4 | $21.5M | Buy |
398,982
+73,404
| +23% | +$3.96M | 0.17% | 150 |
|
|
2019
Q3 | $17M | Buy |
+325,578
| New | +$17M | 0.14% | 168 |
|